Dose Escalation of Once Weekly Oral Vinorelbine Concurrent With Weekly Split Dose Hypofractionated Chest Radiation for Palliation of Advanced Non–Small Cell Lung Cancer: A Phase I/II Study-Reference-Cited by-同舟云学术

Dose Escalation of Once Weekly Oral Vinorelbine Concurrent With Weekly Split Dose Hypofractionated Chest Radiation for Palliation of Advanced Non–Small Cell Lung Cancer: A Phase I/II Study

Published:2011-06 Issue:6 Volume:341 Page:454-459
ISSN:0002-9629
Container-title:The American Journal of the Medical Sciences
language:en
Short-container-title:The American Journal of the Medical Sciences

Author:

Schwarzenberger Paul,Linares Louis,Fariss Anna,Nedzi Lucien,Salazar Omar M.

Publisher

Elsevier BV

Subject

General Medicine

Reference37 articles.

1. Dose escalation of docetaxel concomitant with hypofractionated, once weekly chest radiotherapy for non-small-cell lung cancer: a phase I study;Schwarzenberger;Am J Clin Oncol,2004

2. Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration;Briasoulis;Ann Oncol,1999

3. Weekly administration of docetaxel (Taxotere): summary of clinical data;Hainsworth;Semin Oncol,1999

4. Phase I study of docetaxel with concomitant thoracic radiation therapy;Mauer;J Clin Oncol,1998

5. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer;Schaake-Koning;N Engl J Med,1992

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3 Gy/fraction);La radiologia medica;2019-07-17

2. Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review;Expert Review of Anticancer Therapy;2018-09-17

3. Oral vinorelbine: a narrative review;Cancer Nursing Practice;2018-03-08

4. Efficacy of Metronomic Vinorelbine in Elderly Patients with Advanced Non-Small-Cell Lung Cancer and Poor Performance Status;Current Oncology;2017-06-01

5. Oral vinorelbine: a feasible and safe partner for radiotherapy in the treatment of locally advanced non-small cell lung cancer;OncoTargets and Therapy;2016-04